Medications for Liposarcoma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Liposarcoma.
Found 2 Approved Drugs for Liposarcoma
Yondelis
Generic Name
Trabectedin
Yondelis
Generic Name
Trabectedin
Form: Injection
Method of administration: Intravenous
FDA approval date: October 23, 2015
Classification: Alkylating Drug
YONDELIS ® is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen. YONDELIS is an alkylating drug indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen ( 1 )
Halaven
Generic Name
Eribulin
Halaven
Generic Name
Eribulin
Form: Injection, Solution
Method of administration: Intravenous
FDA approval date: November 15, 2010
Classification: Microtubule Inhibitor
Eribulin Mesylate Injection is a microtubule inhibitor indicated for the treatment of patients with: Metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances